Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
<h4>Background</h4>Cutaneous leishmaniasis (CL) is treated with parenteral drugs for decades with decreasing rate cures. Miltefosine is an oral medication with anti-leishmania activity and may increase the cure rates and improve compliance.<h4>Methodology/principal findings</h4&...
Saved in:
| Main Authors: | Paulo R Machado, Julia Ampuero, Luiz H Guimarães, Leonardo Villasboas, Ana T Rocha, Albert Schriefer, Rosana S Sousa, Anette Talhari, Gerson Penna, Edgar M Carvalho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-12-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000912&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Miltefosine Failure and Amphotericin B Success in the Treatment of a Case of Cutaneous Leishmania Braziliensis in a Recent Traveler in Belize and Guatemala
by: Michelle Y. Ko, et al.
Published: (2025-01-01) -
Miltefosine for the treatment of cutaneous leishmaniasis-A pilot study from Ethiopia.
by: Saskia van Henten, et al.
Published: (2021-05-01) -
Prostaglandin E2 contributes to L. braziliensis survival and therapeutic failure in cutaneous leishmaniasis
by: Maurício T. Nascimento, et al.
Published: (2023-12-01) -
Miltefosine implementation for treatment of cutaneous leishmaniasis: access indicators in the state of Minas Gerais, 2021-2024
by: Sarah Nascimento Silva, et al.
Published: (2025-06-01) -
The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
by: Masoumeh Tayyebi, et al.
Published: (2021-03-01)